Targeting glutamine metabolism enhances responses to platinum-based chemotherapy in triple-negative breast cancers (TNBC).

Genes Dis · 2022 · PMC9485268 · PMID 36157486

Europe PMC DOI

hedged sentence

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

showed a trendP = 0.055so close (0.05 < p ≤ 0.1)

Elevated GLS1 protein expression in TNBCs ( n = 71) showed a trend toward correlation with worse overall survival (HR = 2.258, P = 0.055, log-rank test) ( Fig.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.